Mirna Therapeutics (MIRN): Cutting PT After The MRX34 Program Was Terminated - Leerink

September 21, 2016 9:26 AM EDT Send to a Friend
Leerink Partners analyst, Michael Schmidt, reiterated his Market Perform rating on shares of Mirna Therapeutics. (NASDAQ: MIRN) after the company ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login